Form 4: NeueHealth Executive Tomas Orozco Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


EVP Tomas Orozco sold shares of NeueHealth, Inc. to cover tax withholding obligations upon the vesting of restricted stock units.

Summary

  • On March 11, 2025, Tomas Orozco, an EVP at NeueHealth, Inc., sold 617 shares of common stock at a weighted average price of $6.85 per share to cover tax obligations.
  • On the same day, Orozco exercised 24,000 restricted stock units, receiving 24,000 shares of common stock.
  • On March 12, 2025, Orozco sold 1,300 shares of common stock at a weighted average price of $6.93 per share.
  • Following these transactions, Orozco directly owns 34,091 shares of NeueHealth, Inc.
  • Orozco also directly owns 48,000 restricted stock units, which vest in three equal annual installments beginning on March 11, 2025.

Sentiment

Score: 5

Explanation: The document primarily reports routine stock transactions by an executive. It doesn't contain information that would significantly sway investor sentiment positively or negatively.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. They can be driven by various factors, including tax obligations, diversification, and personal financial planning. Monitoring these transactions can provide insights into executive sentiment and potential future company performance, although individual transactions are not necessarily indicative of broader trends.

Comparison to Industry Standards

  • Executive compensation packages often include restricted stock units that vest over time, aligning executive interests with long-term shareholder value.
  • Sales of shares to cover tax obligations upon vesting are a standard practice.
  • The size of the transactions is relatively small compared to the overall market capitalization of NeueHealth, Inc.

Stakeholder Impact

  • The transactions are unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors.

Key Dates

DateDescription
03/11/2025Date of stock sale (617 shares) and exercise of restricted stock units (24,000)
03/11/2025Vesting start date for restricted stock units in three equal annual installments
03/12/2025Date of stock sale (1,300 shares)
03/13/2025Date of signature by Attorney-in-Fact

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.